AIDX

20/20 Biolabs, Inc.

Name: 20/20 Biolabs, Inc. Q1 2026 Earnings Call
Start: 2026-05-15

AIDX • XNAS

20/20 Biolabs, Inc. is a publicly traded company trading on XNAS, led by CEO Jonathan Cohen, with a market cap of $18.6M.

CEOJonathan Cohen

Market Cap$18.6M

Next Earnings

Upcoming earnings announcement for 20/20 Biolabs, Inc.

Date

Friday, May 15, 2026 (in a month)

Timing

After Market Close (4:58 PM New York)

Fiscal Period

Q1 2026

Past 1 earnings report for 20/20 Biolabs, Inc.

Date	Period	EPS	EPS Surprise	Revenue	Rev. Surprise	Filing
Mar 31, 2026	FY 2025	-$0.76	—	$2.0M	—	—